75 related articles for article (PubMed ID: 17824016)
1. [Molecular mechanisms of lipid metabolism in metabolic syndrome].
Hirata K
Nihon Rinsho; 2007 Jul; 65 Suppl 7():79-83. PubMed ID: 17824016
[No Abstract] [Full Text] [Related]
2. An update on lipidomics: progress and application in biomarker and drug development.
Han X
Curr Opin Mol Ther; 2007 Dec; 9(6):586-91. PubMed ID: 18041669
[TBL] [Abstract][Full Text] [Related]
3. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
Claudel T; Staels B; Kuipers F
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
[TBL] [Abstract][Full Text] [Related]
4. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
Yahia RB; Lichnovská R; Brychta T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
[TBL] [Abstract][Full Text] [Related]
5. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
Lafontan M; Moro C; Sengenes C; Galitzky J; Crampes F; Berlan M
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2032-42. PubMed ID: 16123323
[TBL] [Abstract][Full Text] [Related]
6. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
Ooi EM; Watts GF; Barrett PH; Chan DC; Clifton PM; Ji J; Nestel PJ
Asia Pac J Clin Nutr; 2007; 16(4):624-31. PubMed ID: 18042521
[TBL] [Abstract][Full Text] [Related]
7. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet.
Kume S; Uzu T; Araki S; Sugimoto T; Isshiki K; Chin-Kanasaki M; Sakaguchi M; Kubota N; Terauchi Y; Kadowaki T; Haneda M; Kashiwagi A; Koya D
J Am Soc Nephrol; 2007 Oct; 18(10):2715-23. PubMed ID: 17855643
[TBL] [Abstract][Full Text] [Related]
8. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
Grimaldi PA
Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma: its role in metabolic syndrome.
Pakala R; Kuchulakanti P; Rha SW; Cheneau E; Baffour R; Waksman R
Cardiovasc Radiat Med; 2004; 5(2):97-103. PubMed ID: 15464947
[TBL] [Abstract][Full Text] [Related]
10. Lipid metabolism.
Young IS; Nicholls DP
Curr Opin Lipidol; 2010 Dec; 21(6):550-1. PubMed ID: 21206344
[No Abstract] [Full Text] [Related]
11. Lipidomics in diabetes and the metabolic syndrome.
Gross RW; Han X
Methods Enzymol; 2007; 433():73-90. PubMed ID: 17954229
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome: analogies with subtypes of protein energy malnutrition.
Contaldo F; Sacchetti L; Pasanisi F
Clin Nutr; 2006 Jun; 25(3):537-9. PubMed ID: 16698145
[No Abstract] [Full Text] [Related]
13. Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substances.
Loizzo S; Vella S; Loizzo A; Fortuna A; Di Biase A; Salvati S; Frajese GV; Agrapart V; Ramirez Morales R; Spampinato S; Campana G; Capasso A; Galietta G; Guarino I; Carta S; Carru C; Zinellu A; Ghirlanda G; Seghieri G; Renzi P; Franconi F
Peptides; 2010 Aug; 31(8):1598-605. PubMed ID: 20493223
[TBL] [Abstract][Full Text] [Related]
14. The effect of group-based lifestyle interventions on risk factors and insulin resistance in subjects at risk for metabolic syndrome: the Tabaruzaka Study 1.
Yamashiro T; Nishikawa T; Isami S; Wei CN; Fukumoto K; Matsuo H; Yoshinaga T; Kukidome D; Motoshima H; Matsumura T; Ueda A; Araki E
Diabetes Obes Metab; 2010 Sep; 12(9):790-7. PubMed ID: 20649631
[TBL] [Abstract][Full Text] [Related]
15. Ectopic fat deposition and the metabolic syndrome in obese children and adolescents.
Cali AM; Caprio S
Horm Res; 2009 Jan; 71 Suppl 1():2-7. PubMed ID: 19153496
[TBL] [Abstract][Full Text] [Related]
16. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome.
Aguilera CM; Gil-Campos M; Cañete R; Gil A
Clin Sci (Lond); 2008 Feb; 114(3):183-93. PubMed ID: 18184112
[TBL] [Abstract][Full Text] [Related]
17. Welcome to new insights into 'Metabolic Syndrome'.
Matyus P
Future Med Chem; 2010 Dec; 2(12):1719-20. PubMed ID: 21428793
[No Abstract] [Full Text] [Related]
18. Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme A.
Ruderman NB; Saha AK
Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():25S-33S. PubMed ID: 16642960
[TBL] [Abstract][Full Text] [Related]
19. Intramyocellular lipids: effect of age, obesity, and exercise.
Franklin RM; Kanaley JA
Phys Sportsmed; 2009 Apr; 37(1):20-6. PubMed ID: 20048484
[TBL] [Abstract][Full Text] [Related]
20. 4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome.
Jetté L; Harvey L; Eugeni K; Levens N
Curr Opin Investig Drugs; 2009 Apr; 10(4):353-8. PubMed ID: 19337956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
